1. 1991
  2. Subset markers of CD8(+) cells and their relation to enhanced cytotoxic T cell activity during HIV(+) infection. / Vanham, G; Kestens, L; Penne, L; Goilav, C; Gigase, P; Colebunders, R; Vandenbruaene, M; Goeman, J; van der Groen, G; Ceuppens, JL.

    In: Journal of Clinical Immunology, Vol. 11, 1991, p. 345-356.

    Research output: Contribution to journalA1: Web of Science-article

  3. 1990
  4. Evidence of circulating activated cytotoxic T cells in HIV-infected subjects before the onset of opportunistic infections. / Vanham, G; Kestens, L; Gigase, P; Colebunders, R; Vandenbruaene, M; Brijs, L; Ceuppens, JL.

    In: Clinical and Experimental Immunology, Vol. 82, 1990, p. 3-9.

    Research output: Contribution to journalA1: Web of Science-article

  5. 1989
  6. Susceptibility, pathogenesis and defence in HIV infection; a look at last month's publications. / Vanham, G.

    In: Current AIDS Literature, Vol. 2, 1989, p. 163-164.

    Research output: Contribution to journalA2: International peer reviewed article (not A1-type)

  7. T lymphocytes and their CD4 subset are direct targets for the inhibitory effect of calcitriol. / Vanham, G; Ceuppens, JL; Bouillon, R.

    In: Cellular Immunology, Vol. 124, 1989, p. 320-333.

    Research output: Contribution to journalA2: International peer reviewed article (not A1-type)

  8. 1988
  9. The effect of vitamin D analogs and of vitamin D binding protein on lymphocyte proliferation. / Vanham, G; Van Baelen, H; Tan, BH; Bouillon, R.

    In: Journal of Steroid Biochemistry, Vol. 29, 1988, p. 381-386.

    Research output: Contribution to journalA2: International peer reviewed article (not A1-type)

Previous 1...16 17 18 19 20 Next

ID: 4718